The future of clinical trials is here: the world's first Accelerated Clinical Trials (ACT™) solution.

The Hawthorne Effect ACT™ solution leverages technology, people, and extensive expertise to deliver innovative, accessible, inclusive clinical trials.

Our ACT™ solution combines cutting-edge technology and adaptive processes.

The result is efficient and accurate clinical trials regardless of geography or trial complexity.

Jodi Akin

Founder + CEO

Driven by our dedication to improving the health and well-being of all humanity.

We embrace a dynamic sense of accessibility, accuracy, compassion, and precision in our mission. We are changing the landscape to improve opportunities for patients and the quality and impact of medical research.

Hawthorne Effect is committed to ongoing clinical trials, seeking treatments to improve the health and quality of life for all patients.

Cyclic Vomiting Syndrome
Evaluating the safety and efficacy of new treatments.
Peripheral Arterial Disease

Evaluating the safety and effectiveness of the ESIPIRT™ Bioresorbable stent.

Kidney Transplant

Exploring the efficacy and safety of NPC-21 to combat CMV infection in transplant recipients.

Hawthorne Effect is committed to ongoing clinical trials, seeking treatments to improve the health and quality of life for all patients.